Nanexa AB - Home

VISION & MISSION

Nanexa will be a world leading drug development company for Long Acting Injectables, developing a new generation of innovative drug products enabled by our unique PharmaShell® technology”

In its state-of-the-art pilot plant and labs in Uppsala, Nanexa runs the development of own product projects and collaborative projects with other pharmaceutical companies, based on the PharmaShell® system.

PRESSRELEASES

21 July, 2022

Nanexa extends collaboration agreement with Applied Materials

Nanexa AB (publ) today announced that the company has expanded its collaboration agreement with Applied Materials, Inc., through an amendment regulating commercial arrangements, paving the way for potential future license agreements with customers in the pharmaceutical industry.

9 June, 2022

Bulletin from Nanexa’s Annual General Meeting 2022

The Annual General Meeting (AGM) of Nanexa AB (publ) has been held on June 9, 2022, at which meeting submitted proposals were passed. The complete proposals for resolutions are set out in the AGM notice.